Titre:
  • 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Auteur:Piccart, Martine; van 't Veer, Laura J; Poncet, Coralie; Lopes Cardozo, Josephine JMN; Delaloge, Suzette; Pierga, Jean-Yves; Vuylsteke, Peter; Brain, Etienne; Vrijaldenhoven, Suzan; Neijenhuis, Peter A; Causeret, Sylvian; Smilde, Tineke J; Viale, Giuseppe; Glas, Annuska M; Delorenzi, Mauro; Sotiriou, Christos; Rubio, Isabel Teresa; Kümmel, Sherko; Zoppoli, Gabriele; Thompson, Alastair M; Matos, Erika; Zaman, Khalil; Hilbers, Florentine FS; Fumagalli, Debora; Ravdin, Peter; Knox, Susan; Tryfonidis, Konstantinos; Peric, Aleksandra; Meulemans, Bart; Bogaerts, Jan; Cardoso, Fatima; Rutgers, Emiel J T
Informations sur la publication:Lancet oncology
Statut de publication:Publié, 2021-03-01
Sujet CREF:Cancérologie
Sciences bio-médicales et agricoles
Médecine pathologie humaine
MeSH keywords:Adolescent
Adult
Age Factors
Aged
Anthracyclines -- administration & dosage
Breast Neoplasms -- drug therapy -- genetics -- pathology
Bridged-Ring Compounds -- administration & dosage
Disease-Free Survival
Female
Gene Expression Regulation, Neoplastic -- drug effects
Humans
Middle Aged
Neoplasm Metastasis
Taxoids -- administration & dosage
Transcriptome -- genetics
Treatment Outcome
Young Adult
Langue:Anglais
Identificateurs:urn:issn:1470-2045
info:doi/10.1016/S1470-2045(21)00007-3
info:pii/S1470-2045(21)00007-3
info:pmid/33721561